BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29120671)

  • 1. Erythropoietin reduces collagen deposition after myocardial infarction but does not improve cardiac function.
    Pessoa FG; Mady C; Fonseca KCB; de Oliveira-Fonoff AM; Salemi VMC; Jordão MR; Fernandes F; Ramires FJA
    Can J Physiol Pharmacol; 2018 Jun; 96(6):541-549. PubMed ID: 29120671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of erythropoietin on cardiac remodeling after myocardial infarction.
    Nishiya D; Omura T; Shimada K; Matsumoto R; Kusuyama T; Enomoto S; Iwao H; Takeuchi K; Yoshikawa J; Yoshiyama M
    J Pharmacol Sci; 2006 May; 101(1):31-9. PubMed ID: 16717399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated low-dose of erythropoietin is associated with improved left ventricular function in rat acute myocardial infarction model.
    Ben-Dor I; Hardy B; Fuchs S; Kaganovsky E; Kadmon E; Sagie A; Coleman R; Mansur M; Politi B; Fraser A; Harell D; Okon E; Battler A; Haim M
    Cardiovasc Drugs Ther; 2007 Oct; 21(5):339-46. PubMed ID: 17912622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A small nonerythropoietic helix B surface peptide based upon erythropoietin structure is cardioprotective against ischemic myocardial damage.
    Ahmet I; Tae HJ; Juhaszova M; Riordon DR; Boheler KR; Sollott SJ; Brines M; Cerami A; Lakatta EG; Talan MI
    Mol Med; 2011; 17(3-4):194-200. PubMed ID: 21170473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of erythropoietin combined with granulocyte-colony stimulating factor in the treatment of acute myocardial infarction in rats].
    Fu ZH; Dong W; Gai LY; Wang F; Ding R; Chen YD
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jan; 31(1):17-22. PubMed ID: 21269949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotective effects of erythropoietin in rats subjected to ischemia-reperfusion injury: assessment of infarct size with 99mTc-annexin V.
    Doue T; Ohtsuki K; Ogawa K; Ueda M; Azuma A; Saji H; Strauss HW; Matsubara H
    J Nucl Med; 2008 Oct; 49(10):1694-700. PubMed ID: 18794258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin, modified to not stimulate red blood cell production, retains its cardioprotective properties.
    Moon C; Krawczyk M; Paik D; Coleman T; Brines M; Juhaszova M; Sollott SJ; Lakatta EG; Talan MI
    J Pharmacol Exp Ther; 2006 Mar; 316(3):999-1005. PubMed ID: 16306273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin combined with ACE inhibitor prevents heart remodeling in 5/6 nephrectomized rats independently of blood pressure and kidney function.
    Gut N; Piecha G; Aldebssi F; Schaefer S; Bekeredjian R; Schirmacher P; Ritz E; Gross-Weissmann ML
    Am J Nephrol; 2013; 38(2):124-35. PubMed ID: 23920063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic administration of small nonerythropoietic peptide sequence of erythropoietin effectively ameliorates the progression of postmyocardial infarction-dilated cardiomyopathy.
    Ahmet I; Tae HJ; Brines M; Cerami A; Lakatta EG; Talan MI
    J Pharmacol Exp Ther; 2013 Jun; 345(3):446-56. PubMed ID: 23584743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracardiac injection of erythropoietin induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model.
    Klopsch C; Furlani D; Gäbel R; Li W; Pittermann E; Ugurlucan M; Kundt G; Zingler C; Titze U; Wang W; Ong LL; Wagner K; Li RK; Ma N; Steinhoff G
    J Cell Mol Med; 2009 Apr; 13(4):664-79. PubMed ID: 19449462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single high-dose intramyocardial administration of erythropoietin promotes early intracardiac proliferation, proves safety and restores cardiac performance after myocardial infarction in rats.
    Gäbel R; Klopsch C; Furlani D; Yerebakan C; Li W; Ugurlucan M; Ma N; Steinhoff G
    Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):20-5; discussion 25. PubMed ID: 19380336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin protects post-ischemic hearts by preventing extracellular matrix degradation: role of Jak2-ERK pathway.
    Chan CY; Chen YS; Lee HH; Huang HS; Lai YL; Chen CF; Ma MC
    Life Sci; 2007 Aug; 81(9):717-23. PubMed ID: 17707437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of doxycycline on the expression of matrix metalloproteinase and tissue inhibitor of MMP in myocardium after acute myocardial infarction: an animal experiment with rats].
    Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1288-93. PubMed ID: 15387968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac remodeling by fibrous tissue after infarction in rats.
    Sun Y; Zhang JQ; Zhang J; Lamparter S
    J Lab Clin Med; 2000 Apr; 135(4):316-23. PubMed ID: 10779047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of combination of proliferative agents and erythropoietin on left ventricular remodeling post-myocardial infarction.
    Kanashiro-Takeuchi RM; Takeuchi LM; Hatzistergos K; Quevedo H; Selem SM; Treuer AV; Premer C; Balkan W; Margitich I; Song Y; Hu Q; Hare JM
    Clin Transl Sci; 2011 Jun; 4(3):168-74. PubMed ID: 21707946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local erythropoietin and endothelial progenitor cells improve regional cardiac function in acute myocardial infarction.
    Stein A; Knödler M; Makowski M; Kühnel S; Nekolla S; Keithahn A; Weidl E; Groha P; Schürmann M; Saraste A; Botnar R; Oostendorp RA; Ott I
    BMC Cardiovasc Disord; 2010 Sep; 10():43. PubMed ID: 20849606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic erythropoietin treatment decreases post-infarct myocardial damage in rats without venous thrombogenic effect.
    Prunier F; Pottier P; Clairand R; Mercier A; Hajjar RJ; Planchon B; Furber A
    Cardiology; 2009; 112(2):129-34. PubMed ID: 18596374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury.
    Fiordaliso F; Chimenti S; Staszewsky L; Bai A; Carlo E; Cuccovillo I; Doni M; Mengozzi M; Tonelli R; Ghezzi P; Coleman T; Brines M; Cerami A; Latini R
    Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2046-51. PubMed ID: 15671158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure.
    Li Y; Takemura G; Okada H; Miyata S; Maruyama R; Li L; Higuchi M; Minatoguchi S; Fujiwara T; Fujiwara H
    Cardiovasc Res; 2006 Sep; 71(4):684-94. PubMed ID: 16828072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.